医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(3R,4R)-1-苄基-N,4-二甲基哌啶-3-胺二盐酸盐 | (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride | 1062580-52-2 | C14H24Cl2N2 |
|
(3R,4R)-(1-苄基-4-甲基-哌啶-3-基)-甲基-(7H-吡咯并[2,3-d]嘧啶-4-基)-胺 | N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 477600-73-0 | C20H25N5 |
|
(3R,4R)-(-)-1-苄基-3,4-吡咯烷二醇 | (3R,4R)-1-benzyl-3,4-pyrrolidinediol | 163439-82-5 | C11H15NO2 |
|
(3R,3AS,6AR)-六氢呋喃并[2,3-B]呋喃-3-醇 | (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol | 156928-09-5 | C6H10O3 |
|
(3R)-四氢噻吩-3-醇 | 3-(R)-hydroxytetrahydrothiophene | 100937-75-5 | C4H8OS |
|
(3R)-吡咯烷-3-羧酸盐酸盐 | (R)-pyrrolidine-3-carboxylic acid hydrochloride | 1202245-51-9 | C5H10ClNO2 |
|
(3R)-3-甲酰基-1-吡咯烷甲酸叔丁酯 | (R)-tert-butyl 3-formylpyrrolidine-1-carboxylate | 191347-94-1 | C10H17NO3 |
|
(3R)-3-氯-1-吡咯烷甲酸叔丁酯 | (R)-tert-Butyl 3-chloropyrrolidine-1-carboxylate | 1289585-27-8 | C9H16ClNO2 |
|
(3R)-3-氨基六氢-1H-氮杂卓-1-羧酸叔丁酯 | tert-butyl (R)-3-aminoazepane-1-carboxylate | 1032684-85-7 | C11H22N2O2 |
|
(3R)-(+)-3-(二甲氨基)吡咯烷 | (R)-N,N-dimethylpyrrolidin-3-amine | 132958-72-6 | C6H14N2 |
|
(3E,13Z)-十八碳二烯-1-基乙酸酯 | (3E,13Z)-3,13-octadecadienyl acetate | 53120-26-6 | C20H36O2 |
|
(3AR,7AS)-REL-八氢-1H-异吲哚盐酸盐 | cis-octahydroisoindole hydrochloride | 161829-92-1 | C8H15N*ClH |
|
(3-苯基异-4-喹啉)甲醇 | (3-phenylisoquinolin-4-yl)methanol | 385416-19-3 | C16H13NO |
|
(3-肼基-3-氧代丙基)氨基甲酸叔丁酯 | tert-butyl (3-hydrazinyl-3-oxopropyl)carbamate | 42116-56-3 | C8H17N3O3 |
|
(3-羟基甲基吡啶-2-基)氨基甲酸叔丁酯 | 2-(tert-butoxycarbonyl)amino-3-hydrohymethyl pyridine | 877593-11-8 | C11H16N2O3 |
|
(3-羟基-10,13-二甲基-2,3,4,7,8,9,11,12,14,15,16,17-十二氢-1H-环戊并[a]菲-17-基)苯甲酸酯 | androstenediol-17-benzoate | 1175-12-8 | C26H34O3 |
|
(3-甲氧基苯甲酰)乙酸乙酯 | ethyl (3-methoxybenzoyl)acetate | 27834-99-7 | C12H14O4 |
|
(3-甲氧基苯基)-(4-苯基苯基)甲酮 | [1,1′-biphenyl]-4-yl(3-methoxyphenyl)methanone | 79447-10-2 | C20H16O2 |
|
(3-甲基吡啶-2-基)甲醇 | (3-methylpyridin-2-yl)methanol | 63071-09-0 | C7H9NO |
|
(3-甲基-1,2,4-噁二唑-5-基)甲醇 | (3-methyl-1,2,4-oxadiazol-5-yl)methanol | 112960-56-2 | C4H6N2O2 |
|
(3-溴吡啶-4-基)氨基甲酸叔丁酯 | tert-butyl (3-bromopyridin-4-yl)carbamate | 257937-08-9 | C10H13BrN2O2 |
|
(3-溴丙基)二甲基胺 | N,N-dimethyl-3-bromopropylamine | 53929-74-1 | C5H12BrN |
|
(3-溴-吡啶-2-基)-乙酸乙酯 | ethyl 2-(3-bromopyridin-2-yl)acetate | 197376-41-3 | C9H10BrNO2 |
|
(3-溴-6-氯吡啶-2-基)甲醇 | (3-bromo-6-chloropyridin-2-yl)methanol | 1227601-71-9 | C6H5BrClNO |
|
(3-溴-5-硝基-吡啶-4-基)-乙基-胺 | 3-bromo-N-ethyl-5-nitropyridin-4-amine | 607371-01-7 | C7H8BrN3O2 |
|
(3-氯吡嗪-2-基)甲胺盐酸盐 | (3-chloropyrazin-2-yl)methanamine hydrochloride | 939412-86-9 | C5H6ClN3*ClH |
|
(3-氯吡嗪-2-基)甲胺双盐酸盐 | (3-Chloropyrazin-2-yl)methanamine dihydrochloride | 867165-53-5 | C5H8Cl3N3 |
|
(3-氯二苯-4-基)胺.HCL | 3'-chloro-[1,1'-biphenyl]-4-amine | 5748-36-7 | C12H10ClN |
|
(3-氯-6-氧代哒嗪-1(6H)-基)乙酸 | 2-[6-chloro-pyridazin-3(2H)-one-2-yl]-acetic acid | 89581-61-3 | C6H5ClN2O3 |
|
(3-氮杂双环[3.1.0]-6-己基)-氨基甲酸叔丁酯 | tert-butyl 3-azabicyclo[3.1.0]hexan-6-ylcarbamate | 198211-38-0 | C10H18N2O2 |
|
(3-氨基-5-溴吡啶-2-基)乙酸 | (3-Amino-5-bromopyridin-2-yl)acetic acid | 886373-11-1 | C7H7BrN2O2 |
|
(3-氨基-4-氯苯基)甲醇 | (3-amino-4-chlorophenyl)methanol | 104317-94-4 | C7H8ClNO |
|
(3-氟-4-吡啶)甲胺 | 3-fluoropyridin-4-ylmethanamine | 870063-62-0 | C6H7FN2 |
|
(3-噻吩基)丙二酸二乙酯 | diethyl 3-thienylmalonate | 37784-67-1 | C11H14O4S |
|
(3-嘧啶-5-苯基)甲醇 | (3-(pyrimidin-5-yl)phenyl)methanol | 852180-75-7 | C11H10N2O |
|
(3-(咔唑-9-基)苯基)频哪醇硼酸酯 | 9-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole | 870119-58-7 | C24H24BNO2 |
|
(3-(三氟甲基)吡啶-2-基)甲胺 | 1-[3-(trifluoromethyl)pyridin-2-yl]methanamine | 886371-24-0 | C7H7F3N2 |
|
(3-(5-溴嘧啶-2-基)苯基)甲醇 | (3-(5-bromopyrimidin-2-yl)phenyl)methanol | 1092568-90-5 | C11H9BrN2O |
|
(3,5-二苯基苯)硼酸 | 3,5-diphenylphenylboronic acid | 128388-54-5 | C18H15BO2 |
|
(3,5-二硝基吡啶-2)-甲胺 | 2-Methylamino-3,5-dinitropyridin | 19404-40-1 | C6H6N4O4 |
|
(3,5-二甲基异恶唑-4-基)甲胺 | (3,5-dimethylisoxazol-4-yl)methanamine | 131052-47-6 | C6H10N2O |
|
(3,5-二甲基-4-异恶唑基)甲醇 | 4-hydroxymethyl-3,5-dimethylisoxazole | 19788-36-4 | C6H9NO2 |
|
(3,5-二溴吡啶-4-基)甲醇 | (3,5-dibromopyridin-4-yl)methanol | 197008-13-2 | C6H5Br2NO |
|
(3,4-二甲氧苄基)吡啶-4-基甲胺 | 4-<3,4-Dimethoxy-benzylaminomethyl>-pyridin | 57342-20-8 | C15H18N2O2 |
|
(3'S)-3-氯-1'-(1,1-二甲基乙基)-5,7-二氢螺[6H-环戊[B]吡啶-6,3'-[3H]吡咯并[2,3-B]吡啶]-2'(1'H)-酮 | (S)-1'-(tert-butyl)-3-chloro-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one | 1455358-14-1 | C18H18ClN3O |
|
(2’S)-2’-脱氧-2’-氟-5-乙炔基尿苷 | 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethynyluracil | 95740-26-4 | C11H11FN2O5 |
|
(2Z,6E)-3,7,11-三甲基十二碳-2,6,10-三烯-1-醇 | (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol | 3790-71-4 | C15H26O |
|
(2Z)-4-氧代-4-[3-(三氟甲基)-5,6-二氢-[1,2,4]三唑并[4,3-a]吡嗪-7-(8H)-基]-1-(2,4,5-三氟苯基)丁-2-酮 | 1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione | 764667-65-4 | C16H12F6N4O2 |
|
(2S,6S)-2,6-二甲基哌嗪-1-羧酸叔丁酯 | tert-butyl (2S,6S)-2,6-dimethylpiperazine-1-carboxylate | 574007-66-2 | C11H22N2O2 |
|
(2S,6R)-6-氨基-2-(2-噻吩基)-1,4-硫氮杂卓-5-酮 | (2S,6R)-6-Amino-2-thiophen-2-yl-[1,4]thiazepan-5-one | 110221-26-6 | C9H12N2OS2 |
|